Drugs / BG136
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05984368 | Aug → Sep 2023 | — | The Affiliated Hospital of Qingdao University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG136 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05984368 ↗ |
| Route | Intravenous | “Intravenous infusion administration” NCT05984368 ↗ |